BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3873754)

  • 21. Immunization of haemophiliacs against hepatitis B. A joint study between the haemophilia centers in Leuven, Belgium and Malmö, Sweden.
    Hedner U; Hansson BG; Vermylen J; Verstraete M; Colaert J; Desmyter J
    Scand J Haematol Suppl; 1984; 40():317-21. PubMed ID: 6236549
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
    Wong KH; Liu YM; Ng PS; Young BW; Lee SS
    J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis C antibody and chronic liver disease in haemophilia.
    Makris M; Preston FE; Triger DR; Underwood JC; Choo QL; Kuo G; Houghton M
    Lancet; 1990 May; 335(8698):1117-9. PubMed ID: 1971863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viral serology (hepatitis B virus, cytomegalovirus, Epstein-Barr virus) and abnormal liver function tests in transfused patients with hereditary hemorrhagic diseases.
    Enck RE; Betts RF; Brown MR; Miller G
    Transfusion; 1979; 19(1):32-8. PubMed ID: 219564
    [No Abstract]   [Full Text] [Related]  

  • 26. Hepatitis A in French hemophiliacs.
    Goudemand J; Parquet A; d'Oiron R; Stieltjes N; Guérois C; Fonlupt J; Alcalay M; Négrier C; Cazenave JP; Briquel ME
    Vox Sang; 1994; 67 Suppl 1():9-12; discussion 13. PubMed ID: 8091745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prevalence of serological markers of viral hepatitis A, B and delta in apparently healthy schoolchildren of Huanta, Peru].
    Cabezas C; Gotuzzo E; Escamilla J; Phillips I
    Rev Gastroenterol Peru; 1994; 14(2):123-34. PubMed ID: 7948940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of hepatitis A and E virus infections among healthy children in Mongolia: evidence for infection with a subgenotype IA HAV in children.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Okamoto H
    J Med Virol; 2007 Jan; 79(1):18-25. PubMed ID: 17133554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Herpes and HIV infection in hemophilic subjects].
    Musso A; Riva C; Valpreda A; Perugini L; Negro F; Migliore G
    Minerva Pediatr; 1988 Nov; 40(11):621-4. PubMed ID: 2854606
    [No Abstract]   [Full Text] [Related]  

  • 31. Alteration of T lymphocyte subpopulations in Swedish hemophiliacs.
    Biberfeld G; Blombäck M; Egberg N; Lenkei R; Nilsson IM; Porwit-Ksiazek A
    Scand J Haematol Suppl; 1984; 40():379-82. PubMed ID: 6332375
    [No Abstract]   [Full Text] [Related]  

  • 32. The prevalence of atopy in children with antibodies against hepatitis A virus and hepatitis B virus.
    Kocabaş E; Yapicioğlu H; Yildizdaş D; Güneşer Kendirli S; Burgut R
    Turk J Pediatr; 2006; 48(3):189-96. PubMed ID: 17172060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of hepatitis A virus antibodies in hospital personnel].
    Abb J
    Gesundheitswesen; 1994 Jul; 56(7):377-9. PubMed ID: 7919699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
    Funk M; Ebener U; Kreuz W; Ehrenforth S
    Lancet; 1993 Oct; 342(8876):933-4. PubMed ID: 7692198
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis, epidemiology and liver function in hemophiliacs in Sweden.
    Schulman S; Wiechel B
    Acta Med Scand; 1984; 215(3):249-56. PubMed ID: 6610281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic hepatitis C and risk for hepatitis A infection].
    Chlabicz S; Grzeszczuk A
    Przegl Epidemiol; 2001; 55(3):281-6. PubMed ID: 11761835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular and serologic tracing of a transfusion-transmitted hepatitis A virus.
    Gowland P; Fontana S; Niederhauser C; Taleghani BM
    Transfusion; 2004 Nov; 44(11):1555-61. PubMed ID: 15504159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Seroepidemiology of hepatitis A virus infection in medical and nursing students. The role of vaccination].
    Buti M; Campins M; Jardí R; Navas E; Cotrina M; Llobet E; Vaqué J; Esteban R
    Gastroenterol Hepatol; 1996 Apr; 19(4):199-202. PubMed ID: 8665357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.